tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market
BLTE
Belite Bio, Inc. ADR
RESEARCH TOOLSreports

Belite Bio, Inc. ADR (BLTE) Financial Statements

59 Followers

Belite Bio, Inc. ADR Financial Overview

Belite Bio, Inc. ADR's market cap is currently $6.80B. The company's EPS TTM is $-0.38; its P/E ratio is -69.12; Belite Bio, Inc. ADR is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -198.00K$ -30.00K
Operating Income$ -84.21M$ -40.00M$ -31.67M$ -12.82M$ -9.80M
EBITDA$ -84.21M$ -35.67M$ -31.20M$ -12.43M$ -9.64M
Net Income$ -77.61M$ -36.14M$ -31.63M$ -12.65M$ -9.67M
Balance Sheet
Cash & Short-Term Investments$ 492.42M$ 145.15M$ 88.16M$ 42.09M$ 17.34M
Total Assets$ 780.56M$ 152.13M$ 94.64M$ 44.27M$ 18.35M
Total Debt$ 429.00K$ 537.00K$ 886.00K$ 866.00K$ 31.81M
Net Debt$ -352.50M$ -31.14M$ -87.27M$ -41.22M$ 14.46M
Total Liabilities$ 10.07M$ 6.31M$ 4.21M$ 2.77M$ 33.44M
Stockholders' Equity$ 770.49M$ 145.82M$ 90.43M$ 41.50M$ -15.09M
Cash Flow
Free Cash Flow$ -37.17M$ -29.39M$ -29.90M$ -11.85M$ -7.55M
Operating Cash Flow$ -36.99M$ -29.23M$ -29.84M$ -11.46M$ -7.47M
Investing Cash Flow$ -305.11M$ -110.57M$ -63.00K$ -394.00K$ -56.00K
Financing Cash Flow$ 663.23M$ 83.59M$ 75.96M$ 36.96M$ -583.00K
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

Income Statement >

Belite Bio, Inc. ADR Debt to Assets

Balance Sheet >

Belite Bio, Inc. ADR Cash Flow

Cash Flow >

Belite Bio, Inc. ADR Forecast EPS vs Actual EPS

Earnings >